Reimagining how diseases of malabsorption and nutrient metabolism can be treated
Anagram Therapeutics is leveraging proprietary expertise in gastrointestinal diseases, novel enzyme technologies, and decades of experience to solve complex problems and advance a pipeline of products that can make a life-changing impact for people and their families living with rare diseases.
For diseases like exocrine pancreatic insufficiency and malabsorption syndromes, we're developing a new class of broad-spectrum enzyme replacement therapy to make a meaningful difference. For diseases of carbohydrate malabsorption, we're engineering therapies designed to break down specific carbohydrates and reduce treatment burden.
Anagram is unlocking breakthrough orally delivered enzyme therapeutics engineered for rare, often life-threatening diseases.
Watch the video
